✦ LIBER ✦

Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial

✍ Scribed by Alec Avgerinos; George Rekoumis; Chrisostomos Klonis; Nickos Papadimitriou; Paraskevi Gouma; Stavros Pournaras; Sotos Raptis

Book ID: 117990664
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 819 KB
Volume: 19
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)80586-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preventive therapy of first gastrointest

Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: Results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo

✍ Toni Andreani; Reneé E. Poupon; Beverley J. Balkau; Jean-Claude Trinchet; Jean-D 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 698 KB

Propranolol and endoscopic sclerosis of esophageal varices are the two approaches currently used in prophylaxis of the first gastrointestinal hemorrhage in the cirrhotic patient. One hundred twenty-six cirrhotic patients with esophageal varices and no histories of bleeding were included in the trial

A Randomized Controlled Study of Propran

A Randomized Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis: A Final Report

✍ Didier Lebrec; Thierry Poynard; Jacques Bernuau; Eric Bercoff; Olivier Nouel; Je 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 2 views

We have previously reported the results of a controlled trial showing that continuous oral administration of propranolol reduced the risk of recurrent gastrointestinal bleeding in patients with cirrhosis; only part of our patients had been followed for 1 year. This controlled trial was continued for

Randomized controlled study of propranol

Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis

✍ I. S. Sheen; T. Y. Chen; Y. F. Liaw 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB

β-blockade prevents recurrent gastrointe

β-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial

✍ Massimo Colombo; Roberto de Franchis; Maurizio Tommasini; Angelo Sangiovanni; Ni 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

To assess the efficacy of &blockers in preventing rebleeding in selected cirrhotic patients and to compare the tolerance, safety and patient compliance of a selective and a nonselective @-blocker, 9 4 patients were randomly assigned to propranolol (32 patients), atenolol (32 patients) or placebo (30

Does elective sclerotherapy improve the

Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial

✍ Olivier Ink; Thierry Martin; Thierry Poynard; Marc Reville; Marie-Laure Anciaux; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 931 KB

We conducted a prospective, multicenter, randomized trial to compare the efficacy of sclerotherapy plus propranolol with that of propranolol alone in the prevention of recurrent gastroesophageal bleeding in severely cirrhotic patients. For 2 yr (1987 to 1988) 131 patients (96% of whom were alcoholic

Propranolol for prevention of recurrent

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A prospective study of factors associated with rebleeding

✍ Thierry Poynard; Didier Lebrec; Patrick Hillon; Raymond Sayegh; Jacques Bernuau; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

In a previous randomized trial, we demonstrated that propranolol prevented recurrent gastrointestinal bleeding in patients with cirrhosis. We have undertaken the present study in a new group of patients to ascertain the factors associated with rebleeding. Among 232 patients with cirrhosis admitted f